All Posts

by Vista Partners LLC November 5, 2025

S&P 500, Dow, Nasdaq & Russell Snap Back —Nov. 5, 2025 -( $AMZN $AVGO $CAT $INTC $LLY $MCD $META $MTWO $NOK $OPEN $SER $SOAR $TSLA Rise!)

Wall Street ushered in Wednesday, November 5, 2025 with a refreshed dose of optimism—and just a dash of sophisticated exasperation—as major indices snapped back from recent turbulence driven by AI sector jitters and global macroeconomic suspense. The S&P 500 closed at 6,796.29, notching a gentle 0.37% gain and demonstrating that, on occasion, even Wall Street’s favorite benchmark appreciates a steady incline over a gymnastic leap. The Dow Jones Industrial Average ascended 225.76 points to finish at 47,311, up 0.48% on the session thanks to pronounced rebounds from industrials and, somewhat poetically, Caterpillar’s surprising 3.94% rally—a move surely envied by market cats still stuck in the bear trap. Nasdaq shrugged off its recent fever, climbing to 23,499.80, up 0.65%, with technology titans supporting the recovery even as valuations remained, as the Supreme Court would say, “under review”. The Russell 2000 Index took the opportunity to outperform, rising to 2,464.78 for a relatively robust 1.54% gain, perhaps emboldened by small-cap contrarians insisting that “size isn’t everything” after all. The VIX index, the market’s fear gauge that shot up recently, retreated to $18.01,-5.21% suggesting a muted appetite for drama (financial kind, not Emmy-winning).

Macroeconomic Reports and Federal Reserve

Wednesday’s ‘shutdown reduced’ parade of macroeconomic reports spotlighted a steady recovery in U.S. services activity, mild job market improvement, and subdued inflation expectations. Treasury yields drifted with the 2-yr ending at 3.638% and the 10-yr ending at 4.16% in anticipation of next week’s FOMC statement—expected November 13—where the market hopes Fed officials will clarify their stance on rate hikes amid “higher for longer” speculation.

Tariffs and Government Shutdown Drama

Global headlines circled around the Supreme Court’s live hearings on Trump-era tariffs, with legal arguments diving into whether the existing tariff regime can withstand judicial scrutiny. Washington’s shutdown saga simmered with bipartisan maneuvering, as November’s payroll data and upcoming CPI report loom. No new shutdown deadlines were breached today, but if Congress was a market sector, it would surely get downgraded on “headline risk” alone.

Noteworthy Company News and Performance

Eli Lilly (LLY): Reached a new 52-week high at $955.41 before settling at $925.81, on continued enthusiasm for its diabetes and obesity drugs, and positive trial data released this week.
NVIDIA: Closed at $195.21, down 1.75% as AI chip stocks took a breather, but long-term investors cited institutional accumulation and ongoing demand for Blackwell GPUs supporting future growth.
Nokia: Shares edged higher to $6..85, +.59%.
Amazon: Finished at $250.20, +.35% recently moving higher as bullish analyst sentiment centered on AWS growth, fueled by Anthropic’s massive cloud compute needs.
Apple: Wrapped up at $270.14, +.04% during a quiet session after last week’s robust Q4 earnings.
Tesla: Ended at $462.07, +4.01% recapturing investor favor after October’s rocky autopilot headlines.
Broadcom: Closed at $358.98, up 2% as expansion in cloud and wireless markets balanced sector volatility.
Meta: Closed at $635.95, +1.38% as surging AI investment continues to bolster long-term expectations despite near-term margin anxiety.
McDonald’s (MCD): Rose to $305.67,+2.16% after reporting resilient performance in international markets.
Rio Tinto Group (RIO): Metals fell back as iron ore prices retreated, with Rio Tintorising to $69.06, +1.72% reaffirming fiscal discipline in Q4 guidance (no new acquisitions announced).
Oracle: Settled at $250.31, +.86% down nearly 12.52% over the last month, mirroring broader sector skepticism about high valuations despite massive new contracts and ambitious AI growth targets.
Intel: Closed at $38.38, jumping 3.65% higher after recent volatility related to server chip deman.
Opendoor (OPEN): Closed at $7.23, +4.48% prior to tomorrow’s earnings call.

Commodities and Crypto

Gold closed near $3,992.40 an ounce, silver at $47.93, and oil fell to $59.63 a barrel—each reflecting a world that finds comfort in tangible things, just as Bitcoin, recovered to $103,623.07, reminded traders that volatility is truly a digital art form.

VP Watchlist Updates

Modular Medical, Inc. (Nasdaq: MODD), a leader in innovative insulin delivery technology, announced (Nov. 3) the successful validation of its Pivot controller line, a critical milestone in preparing for the commercial launch of its Pivot patch pump targeted for Q1 2026. The Pivot controller line validation further demonstrates manufacturing readiness for high-volume production, positioning Modular Medical to meet the growing demand in the diabetes treatment market for advanced technology.

Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize local, controlled drug delivery for diseases with significant unmet need, announced (Nov. 4) its financial results for the third quarter of 2025 and provided a business update. Dr. James Helliwell, Chief Executive Officer of Eupraxia stated, “The compelling 52-week data from our RESOLVE trial reported this quarter further reinforce the potential of EP-104GI as a highly effective and durable treatment for eosinophilic esophagitis (EoE). Our highest-dose cohort delivered the largest improvements in tissue health outcomes and eosinophil reduction observed to date, with no additional safety concerns. Coupled with the successful completion of our $80.5 million financing supported by strong life-science focused investors, we are now well resourced to advance the EP-104GI program, including through topline data from the Phase 2b RESOLVE Trial expected in the third quarter of 2026.”

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, announced that it will report its financial results for the quarter ended September 30, 2025, after the close of U.S. markets on Thursday, November 13, 2025. Following the release, management will host a live conference call and audio webcast at 4:30 p.m. ET to review results and provide a business update.

Volato Group, Inc. (NYSE American: SOAR, $1.70, +6.92%) and M2i Global, Inc. (MTWO, $.1025, +2.50%) announced (Oct. 16) the next phase of development of the digital and commercial infrastructure underpinning the U.S. Strategic Mineral Reserve (SMR). M2i initiated the SMR framework and technical specifications earlier this year. Volato is now applying its proven enterprise-software expertise to build and operationalize the secure technology backbone that will support critical mineral traceability, contracting, and compliance across the United States and allied nations. This infrastructure is being developed to serve as the market-facing layer of the U.S. Strategic Mineral Reserve initiative, providing miners, refiners, recyclers, manufacturers, and government entities with a trusted environment for physical critical mineral transactions—with verified provenance, end-to-end custody visibility, and regulatory compliance at its core.

Serina Therapeutics (NYSE American: SER, $4.33, +.07%) stands at a pivotal juncture as it harnesses fresh capital, regulatory momentum, and a sharpened communications strategy to propel its lead program, SER-252, into late-stage clinical testing for advanced Parkinson’s disease. The Alabama-based biotech is betting its proprietary POZ platform and reimagined approach to apomorphine delivery may redefine the treatment paradigm for patients who have exhausted standard oral therapies.

The InterGroup Corporation (NASDAQ: INTG) reported results (Oct. 9) for the fiscal year ended June 30, 2025, including improved segment income in Hotel and Real Estate, increased liquidity, the alleviation of going-concern uncertainty at majority-owned subsidiary Portsmouth Square, Inc., and the Company’s return to compliance with Nasdaq listing requirements.

Sources

by Vista Partners LLC November 5, 2025

Eupraxia Pharmaceuticals Drives Pipeline Expansion with $89 Million in Cash and Positive RESOLVE Trial Results -( $EPRX $IBB $XBI )

Eupraxia Pharmaceuticals (EPRX) delivered an impressive third quarter for 2025, underpinned by breakthrough clinical data, robust financial positioning, and a clearer trajectory toward commercial success. The company’s RESOLVE trial in eosinophilic esophagitis (EoE) demonstrated sustained clinical remission and long-lasting improvements in tissue health after a single treatment—results that highlight the significant potential of Eupraxia’s proprietary EP-104GI therapy.

Strong Clinical Momentum

The RESOLVE trial’s 52-week findings showed that two-thirds of patients in the highest-dose cohort maintained clinical remission, with durable improvements in both symptoms and esophageal tissue health over a full year. These clinical gains, achieved without new safety concerns, position EP-104GI as a major innovation in EoE care with potential advantages over existing therapies’.

Eupraxia continues to enroll patients in the pivotal Phase 2b segment of RESOLVE, with top-line data expected in the third quarter of 2026. The strength of the 1-year clinical outcomes and the scalability of the trial signal exceptional potential for broad adoption.

Solid Financial Performance

Eupraxia secured $80.5 million in funding through a public offering completed in September 2025, resulting in a substantial cash runway projected to fund ongoing development and operations into the first half of 2028. This positions Eupraxia to expand its clinical programs and deliver key milestones without near-term financing concerns. The company’s strong fiscal management and continued support from leading life-sciences investors further reinforce confidence in its future trajectory.

Outlook – The Right Dose, the Right Place, the Right Amount of Time

Buoyed by clinical achievements and a substantial cash position, Eupraxia Pharmaceuticals (EPRX) is on track to deliver further value for patients and shareholders through 2026 and beyond. The latest data showcase the company’s leadership with its DiffusphereTM drug delivery technology for the treatment of eosinophilic esophagitis (EoE), EP-104IAR for knee osteoarthritis (OA), and its increasing relevance in addressing significant unmet needs in other inflammatory diseases, pain conditions and oncology indications..

Sources

by Vista Partners LLC November 5, 2025

Snack Wraps Unwrapped: McDonald’s Nostalgic Menu Move Ignites Sales Surge -( $MCD $DIA $SPY )

McDonald’s has proven that nostalgia can be a lucrative business strategy, as the prodigal Snack Wrap has returned to its American menu after a nine-year hiatus—and promptly delivered a performance worth clucking about. In the fast-paced world of fast food, nothing gets customers flocking quite like the promise of crispy chicken wrapped in the warm embrace of a flour tortilla. The third quarter of 2025 illustrated this perfectly, with McDonald’s reporting a 3.6% rise in same-store sales worldwide and a 2.4% increase stateside, numbers that gently nudged Wall Street’s forecast aside as if it were yesterday’s cold fries.

Nostalgia, Chicken, and Surging Sales

Enthusiasts mourned the loss of the Snack Wrap when it was unceremoniously shelved in 2016, but their devotion never waned. From petitions to homegrown imitations, fans made it clear that a drive-thru without its Snack Wrap was a drive-thru missing its soul. McDonald’s, perhaps with a raised eyebrow at the viral videos of Americans traveling abroad to sample Irish Snack Wraps, finally acquiesced. The July reintroduction was met with a 15% surge in U.S. store traffic on release day, as if millions pivoted in choreographed unison from their summer salads to indulge in chicken-laced nostalgia.

Value Meals and Deal Drama

While the Snack Wrap’s lovestruck fanbase made headlines, McDonald’s also rolled out Extra Value Meals, aiming to seduce back customers repelled by rising fast-food prices. The $8 Big Mac meal generated mild excitement, though data analysts later revealed that nothing quite matched the seductive allure of the 50-cent double cheeseburger special on National Cheeseburger Day—a fleeting flash of indulgence that made wallets sing and cardiologists cringe.

The Market’s Taste for Chicken

Chicken’s popularity continues to soar—not just among birds—prompting CEO Chris Kempczinski to declare investments in expanding the chain’s chicken portfolio. Looking ahead, new chicken-centric menu items are forecasted, with hopes of capturing even more market share in a high-stakes battle featuring the likes of Chick-fil-A and Wendy’s.

Financials, with a Side of Humor

For the quarter, McDonald’s posted $7.08 billion in revenue—a 3% bump—and a net income of $2.3 billion, or $3.18 per share, a sum that missed analyst expectations only slightly, as if distracted by the allure of a side order of fries.

Closing Observations

It seems, in the calculus of modern dining, nothing is as comforting as the familiar. After all, when the world gets complicated, Americans have a simple solution: wrap it up in a tortilla and call it dinner. McDonald’s Snack Wrap’s triumphant return proves that sometimes, you really can go home again—and if you do, make sure to bring a coupon.

Sources

by Vista Partners LLC November 5, 2025

AI Could Outsmart Humanity: Nobel Laureate Hinton Offers Stark Warning—‘Musk Will Get Richer, People Will Get Unemployed’ -( $TSLA $NVDA $GOOG $META )

Geoffrey Hinton, the “Godfather of AI,” is sounding an alarm that could shatter Silicon Valley’s favorite narrative: the notion that artificial intelligence, like a well-trained dog, will sit, stay, and obey. Fresh off his Nobel Prize win for machine learning, Hinton spends less time celebrating breakthroughs and more time warning about existential risk—and, in classic Wall Street fashion, he’s not above sprinkling in a few wry jabs along the way.youtube

AI Risks: Smarter Than Your Average Mogul?

Hinton’s assessment, delivered with the mix of gravitas and dry humor befitting a Nobel laureate, is blunt: humanity is building “aliens” that could outsmart their creators within a decade, and our best chance at coexistence might require channeling the evolutionary model of babies controlling mothers—though, he quips, “hopefully not Jewish mothers” for the sake of sanity. Don’t expect tech CEOs—blessed with outsize confidence—to embrace that unsettling paradigm anytime soon.youtube

Corporate Responsibility: A Mixed Bag

Hinton doesn’t mince words when it comes to corporate stewardship. While Anthropic and Google get a tepid nod for taking AI safety “fairly seriously,” Meta is labeled “particularly irresponsible.” OpenAI, initially founded for responsible innovation, gets dinged for losing its best safety researchers as commercial pressures take precedence. “They’re much more concerned about the race than about whether humanity will survive it,” he warns, dryly noting the irony that survival isn’t the top priority for companies chasing multi-trillion dollar valuations.youtube

Global Collider: U.S., China, and Funding Woes

The race isn’t just corporate; it’s geopolitical. Hinton suggests the U.S., still a hair ahead, risks losing the AI lead as China educates armies of engineers while America “attacks” basic science funding and its own research universities. If that’s a strategy, Hinton suggests, it’s one that seems to benefit Beijing more than Washington—making former presidents look less like defenders of the West and more like unwitting pawns in a global chess match.youtube

Musk Will Get Richer, You Might Get Unemployed

Hinton’s economic forecast lands with the subtlety of a falling safe: waves of AI investment knocking out jobs at an “unprecedented” rate, exemplified by Amazon’s recent 4% workforce cut. The trillion-dollar AI spend won’t just pay off in chatbots; it’s likely to enrich tech plutocrats (yes, Elon Musk gets a namecheck as a “stand-in”) while the layoff tide sweeps through call centers, factories, and offices everywhere. Hinton points out, with a twinkle, that a company’s most obvious path to profits is swapping expensive humans for cheaper algorithms—a strategy that should make labor market watchers reach for their seatbelts.youtube

Is This Time Different? Hold the Optimism

When asked whether this epochal technological leap will follow previous patterns of job creation amidst disruption, Hinton offers skepticism. Unlike steam engines, which were powerful but dumb, today’s AI is “almost as smart as us,” and soon, potentially smarter. Facing permanent unemployment, workers won’t just be swapping shovels for keyboards—they might struggle to find work at all.youtube

Looking for a “Chernobyl Moment”

Ever the realist, Hinton compares the situation to the Cuban missile crisis and, for those craving a jolt of urgency, suggests a failed attempt at AI takeover might be our best wake-up call—a “Chernobyl for AI,” if you will. Until then, don’t expect Big Tech to divert significant resources into safety protocols; for now, profit and ego are running the show.youtube

The Wrap-Up: The Godfather’s Regrets?

In a rare moment of pause, Hinton admits that, unlike nuclear weapons, AI isn’t built solely for destruction. It offers promise in healthcare and education, among other fields. The problem, he quips, is organization—not the tech. “Musk will get richer, a lot of people get unemployed, and Musk won’t care.” The joke, of course, is on all of us—not just on Wall Street.

So if the world needs a “scare” to take AI risks seriously, maybe there’s still hope. Until then, keep calm, carry on, and—if you’re a CEO—start practicing baby talk. The next generation of intelligence might not be so keen on taking orders.

https://www.youtube.com/watch?v=e1Hf-o1SzL4

by Vista Partners LLC November 4, 2025

Nvidia Becomes First Company With $5 Trillion Market Capitalization

Nvidia (NVDA) becomes the first company to ever have a market capitalization of over $5 trillion. Shares rallied Wednesday morning to push Nvidia over the milestone as CEO Jensen Huang seals more deals to supply companies with chips. Bloomberg’s Caroline Hyde reports on “Bloomberg Open Interest.”

by Vista Partners LLC November 4, 2025

Amazon-Backed Beta Technologies Debuts IPO on NYSE: Electric Aircraft Startup Flies High with $1B IPO -( $AMZN $BETA )

Beta Technologies kicked off its inaugural trading session on the New York Stock Exchange with a dramatic flourish that could make even the most seasoned Wall Street veterans glance skyward—if only to keep an eye out for any electric planes barreling toward their offices. The Vermont-based upstart not only soared past expectations by raising over $1 billion, but closed its first day in the green, leaving competitors Joby Aviation and Archer Aviation nursing their wounds and perhaps rethinking their own flight plans.

A Billion-Dollar Takeoff

Beta (BETA) set its IPO price at $34 per share, a solid leap over its predicted range of $27 to $33, while shares hit a intraday high of $38.01. The opening performance may not have matched the theatrics of its electric aircraft, with the stock dipping briefly after the bell before rebounding and closing at $36. That quick recovery left the firm with a valuation just shy of $7.5 billion. For founder and CEO Kyle Clark—Harvard graduate, former hockey pro, and self-appointed test pilot—the day was less about cruising altitude and more about celebrating a Vermont IPO milestone with the enthusiasm of a game-winning slapshot.

Unconventional Pathways, Quirky Culture

Clark’s methods for building Beta Technologies are as unconventional as electric aircraft at a runway dominated by Boeing and Airbus. Not only did he skip Silicon Valley, opting to stay in Vermont, but Clark shunned the usual venture capital labyrinth in favor of institutional investors like Fidelity, Amazon, and GE Aerospace. His management philosophy? Everyone learns to fly—engineers, artists, even the company chef—so Beta’s employees are as comfortable in the cockpit as at the drawing board.

Inside Beta headquarters, you might spot a few flying unicorns—literally. The tail numbers on their prototype aircraft are pronounced “Unicorn Tango” by Clark’s wife, much to the amusement (and occasional irritation) of air traffic control. Junior engineers are encouraged to challenge veterans, sometimes in midair—and sometimes in meetings. Skeptics might ask if flat organizational structures ever level out turbulence, but Beta’s team seems to thrive on the headwinds.

IPO Under Unusual Circumstances

Just for extra drama, Beta filed its IPO paperwork during a government shutdown, leveraging an SEC loophole that lets paperwork become effective without staff review after 20 days. As Wall Street held its breath, Beta pressed ahead, perhaps with some of the same boldness Clark shows during aerobatic test flights.

Market Impact and Flying Into the Future

While the stock’s first day ride was tamer than Beta’s aircraft prototypes, the ripple effect was immediate: Joby Aviation and Archer Aviation saw their own shares drop as investors recalibrated their visions of eVTOL futures. Beta’s revenue doubled in the first half of 2025, reaching $15.6 million, though losses widened to $183 million—because nothing says “disruptive growth” like burning cash to launch planes, careers, and IPOs, all from a runway in Vermont.

In closing, it’s safe to say that Beta Technologies played its market debut less like a cautious co-pilot and more like a captain swooping low to thrill the crowd—a reminder that sometimes, in aviation and investing, the best way to stay above water is to take flight and hope the unicorns know where they’re going.

Sources

by Vista Partners LLC November 4, 2025

Stocks Retreat As Fear & Uncertainty Surge On Election Day, Nov. 4, 2025 – ( $AAPL $HTZ $LLY $MTSR $PAY $SANM $VIX $XMTR Rise!)

In sum, today’s market action reflected deepening caution across asset classes, with macro and policy uncertainties intersecting management commentary for a more sober market tone. Investors are closely watching congressional negotiations on Election Day to end the government shutdown and anticipate further color from the Federal Open Market Committee in coming weeks as rate cut bets recede and leadership rotation takes center stage. Indeed, U.S. equity markets retreated Tuesday as investors weighed artificial intelligence sector valuations against broader macroeconomic risks, with the S&P 500 closing down 1.17% to 6,771.55, Nasdaq sliding 2.04% to 23,348.64, and the Dow Jones Industrial Average dropping 0.53% to 47,085.24. The Russell 2000 finished at 2,427.34, off 1.78% and reflecting small-cap softness after last week’s record high. Sector rotation continued, with technology stocks leading declines amid increased scrutiny on forward guidance and earnings sustainability. The markets fear gauge, CBOE Volatility Index (VIX) rose sharply by 10.64% to close at $19 and is now up +15.71% over the last 5-days.

Relatively recent macroeconomic reports have painted a mixed picture: The ISM Manufacturing PMI registered 48.7, signaling contraction, while employment and new orders indices also hovered below 50, reinforcing caution on U.S. manufacturing momentum. Vehicle sales came in at a modest 15.3 million units, and the RCM/TIPP Economic Optimism Index dropped to 43.9, reflecting consumer uncertainty. However, the absence of comprehensive government data releases persisted due to the ongoing shutdown, stalling GDP and labor market reporting. The yield curve drifted lower today, with the 10-year Treasury note edging down to 4.087% and the 2-year closing down at 3.582% and worried market participants awaited clarity from multiple Federal Reserve speakers on the future path for policy rates.

Among key stocks, Eli Lilly (LLY) gained 1.15% to $906.86 as renewed optimism drove the sector after reports of a $149-per-month White House deal for obesity drugs and plans for a $3 billion Dutch manufacturing facility to scale oral weight-loss production. NVIDIA (NVDA, $198.69, -3.96%), Apple (AAPL, $270.04,+.45%), and Amazon (AMZN, $249.32, -1.84%) all faced some downward pressure as AI leadership valuations were called into question, despite strong third-quarter prints and the US is not interested in NVIDIA selling its Blackwell, most avcanced AI chip, to China. Meanwhile, Palantir Technologies slid 7.94% after reporting robust quarterly results but failing to meet market expectations for FY26 guidance.

The week’s corporate calendar was stacked with deal activity: No major U.S. IPOs or take-private announcements emerged as of Tuesday, and global M&A headlines remained subdued. The latest development on tariffs came from a weekend summit where U.S.-China negotiators extended a truce and eased select export restrictions. Meanwhile, public sentiment reflected anxiety, with 47% of Americans now viewing the trade deficit as an economic emergency—a backdrop amplified by the Supreme Court’s review of the legality of presidential tariffs powers this week.

Commodities retreated in tandem: Gold prices slipped below $4,000 per ounce, falling to $3,997 (-0.14%), silver weakened to $47.68 an ounce (-0.86%), and Brent crude oil declined to $60.36 a barrel (-1.16%) as OPEC+ announced a pause in production hikes and the rising dollar weighed on metals and energy. Bitcoin traded $100k amid profit-taking and lackluster momentum.

Top Performers

Hertz Global Holdings (HTZ) shares skyrocketed up to 40% today, fueled by a classic short-squeeze following an upside earnings surprise. The company delivered Q3 revenue of $2.48 billion (beating estimates), and an EPS of $0.12, swinging from a loss last year. The surprise profit, strategic restructuring, and new executive appointments renewed investor enthusiasm, with retail traders driving volume to meme-stock levels. High short interest above 40% added to the dramatic move.

Xometry, Inc. (XMTR) surged by as much as 24% intraday, nearing a fresh 52-week high at $60.05. The rally followed record Q3 results: revenue jumped 28% year-over-year to $180.7 million, and the company turned adjusted EBITDA positive. Marketplace revenue grew 31%, and Xometry lifted its full-year outlook, powered by demand for its AI-driven manufacturing platform. The strong beat reinforced its leadership in industrial AI amid sector volatility.

Paymentus Holdings’ (PAY) stock continued recent upward momentum, trading at $29.46, though analysts remain cautious on longer-term prospects. Technically, it holds buy signals in the near term, but the long-term trend remains negative. Recent financials showed strong revenue growth (41.9% for 2024), earnings nearly doubled, and analyst consensus rates the stock as a Buy with a 12-month price target of $36.50.

Metsera, Inc. (MTSR) soared between 16% and 20% intraday amid a fierce bidding war between Pfizer and Novo Nordisk, with takeover offers escalating. Novo Nordisk boosted its bid to $62.20 per share, valuing Metsera at $10 billion—deemed superior to Pfizer’s proposal. Investors reacted positively to this acquisition drama, and the FTC’s early green light for Pfizer’s initial buyout plan added to the excitement.

Sanmina Corporation (SANM) rallied over 16% to a new high of $166.96 after posting strong quarterly results. Q4 revenue was $2.1 billion (up 4% year-over-year), with adjusted EPS of $1.67 (beating forecasts). Management issued robust Q1 guidance, driven by demand from its ZT Systems acquisition and cloud/AI infrastructure buildouts. Investors responded enthusiastically to the company’s strategic expansion in tech and AI, which also led to a significant boost in deferred revenue and cash flow.

VP Watchlist Updates

Modular Medical, Inc. (Nasdaq: MODD), a leader in innovative insulin delivery technology, announced (Nov. 3) the successful validation of its Pivot controller line, a critical milestone in preparing for the commercial launch of its Pivot patch pump targeted for Q1 2026. The Pivot controller line validation further demonstrates manufacturing readiness for high-volume production, positioning Modular Medical to meet the growing demand in the diabetes treatment market for advanced technology.

Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology to optimize local, controlled drug delivery for diseases with significant unmet need, announced (Nov. 4) its financial results for the third quarter of 2025 and provided a business update. Dr. James Helliwell, Chief Executive Officer of Eupraxia stated, “The compelling 52-week data from our RESOLVE trial reported this quarter further reinforce the potential of EP-104GI as a highly effective and durable treatment for eosinophilic esophagitis (EoE). Our highest-dose cohort delivered the largest improvements in tissue health outcomes and eosinophil reduction observed to date, with no additional safety concerns. Coupled with the successful completion of our $80.5 million financing supported by strong life-science focused investors, we are now well resourced to advance the EP-104GI program, including through topline data from the Phase 2b RESOLVE Trial expected in the third quarter of 2026.”

GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, announced that it will report its financial results for the quarter ended September 30, 2025, after the close of U.S. markets on Thursday, November 13, 2025. Following the release, management will host a live conference call and audio webcast at 4:30 p.m. ET to review results and provide a business update.

Volato Group, Inc. (NYSE American: SOAR) and M2i Global, Inc. (MTWO) announced (Oct. 16) the next phase of development of the digital and commercial infrastructure underpinning the U.S. Strategic Mineral Reserve (SMR). M2i initiated the SMR framework and technical specifications earlier this year. Volato is now applying its proven enterprise-software expertise to build and operationalize the secure technology backbone that will support critical mineral traceability, contracting, and compliance across the United States and allied nations. This infrastructure is being developed to serve as the market-facing layer of the U.S. Strategic Mineral Reserve initiative, providing miners, refiners, recyclers, manufacturers, and government entities with a trusted environment for physical critical mineral transactions—with verified provenance, end-to-end custody visibility, and regulatory compliance at its core.

Serina Therapeutics (NYSE American: SER) stands at a pivotal juncture as it harnesses fresh capital, regulatory momentum, and a sharpened communications strategy to propel its lead program, SER-252, into late-stage clinical testing for advanced Parkinson’s disease. The Alabama-based biotech is betting its proprietary POZ platform and reimagined approach to apomorphine delivery may redefine the treatment paradigm for patients who have exhausted standard oral therapies.

The InterGroup Corporation (NASDAQ: INTG) reported results (Oct. 9) for the fiscal year ended June 30, 2025, including improved segment income in Hotel and Real Estate, increased liquidity, the alleviation of going-concern uncertainty at majority-owned subsidiary Portsmouth Square, Inc., and the Company’s return to compliance with Nasdaq listing requirements.

Sources

https://goldprice.org

https://www.morningstar.com/news/marketwatch/20251104112/stocks-are-falling-for-reasons-that-go-beyond-ai-jitters

https://www.nasdaq.com/market-activity/index/comp/historical

https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-11-04-2025

https://finance.yahoo.com/quote/%5ERUT/history/

https://tradingeconomics.com/united-states/stock-market

https://tradingeconomics.com/united-states/calendar

https://www.barrons.com/livecoverage/stock-market-news-today-110425

https://home.treasury.gov/news/press-releases/sb0301

https://www.benzinga.com/trading-ideas/movers/25/11/48634128/eli-lilly-novo-nordisk-stocks-rise-on-reported-149-obesity-drug-deal-with-white-house

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-build-3-billion-dutch-plant-boost-weight-loss-pill-production-2025-11-03/

https://www.reuters.com/world/us/poll-shows-47-americans-see-large-us-trade-deficit-economic-emergency-2025-11-04/

https://finance.yahoo.com/personal-finance/investing/article/gold-price-today-tuesday-november-4-2025-gold-opens-above-4000-softens-in-early-trading-133421467.html

https://www.reuters.com/world/india/gold-holds-under-4000-dollar-resilience-fed-rate-cut-outlook-2025-11-04/

https://www.tesaaworld.com/en/news/oil-prices-decline-due-to-opec-decision-manufacturing-indicators-falter-and-dollar-rises

https://www.jmbullion.com/charts/gold-price/

https://tradingeconomics.com/commodity/silver

https://tradingeconomics.com/commodity/brent-crude-oil

https://fortune.com/article/current-price-of-silver-11-4-2025/

https://www.imf.org/en/Publications/WEO

https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-novo-nordisk-near-white-house-deal-obesity-drug-prices-endpoints-new-2025-11-04/

https://seekingalpha.com/news/4514411-eli-lilly-novo-us-deals-obesity-drug-prices

https://finance.yahoo.com/news/international-markets-lilly-lly-deep-141502131.html

https://finance.yahoo.com/news/weighed-eli-lilly-company-lly-121814097.html

https://www.zacks.com/stock/news/2784395/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know

https://www.lilly.com/news/press-releases

https://www.insidermonkey.com/blog/heres-what-weighed-on-eli-lilly-and-companys-lly-performance-1639593/?amp=1

https://247wallst.com/investing/2025/11/04/stock-market-live-november-4-sp-500-voo-tumbles-after-palantir-report-goldman-sachs-warning/

https://www.marketwatch.com/story/stocks-are-falling-for-reasons-that-go-beyond-ai-jitters-737e32cc

https://finance.yahoo.com/quote/%5EGSPC/history/

https://www.investing.com/analysis/november-2025-monthly-outlook-global-economy-limps-with-headwinds-building-200669484

https://www.bloomberg.com/news/articles/2025-11-03/stock-market-today-dow-s-p-live-updates

https://www.cnbc.com/2025/11/02/stock-market-today-live-updates.html

https://www.cnbc.com/2025/11/03/stock-market-today-live-updates.html

https://finance.yahoo.com/quote/%5ENDX/history/

https://ir.nasdaq.com/stock-information/historic-stock-lookup

https://www.investing.com/indices/nasdaq-composite-historical-data

https://www.statmuse.com/money/ask/dow-jones-industrial-average-price-from-1st-jan-2024-to-today

https://www.investing.com/indices/smallcap-2000-historical-data

https://fred.stlouisfed.org/series/NASDAQCOM

https://www.investing.com/indices/us-30-historical-data

https://finance.yahoo.com/quote/NDAQ/history/

https://finance.yahoo.com/quote/%5EDJI/history?period1=1356969600&period2=1451491200&interval=1d&filter=history&frequency=1d

https://www.wsj.com/market-data/quotes/index/RUT/historical-prices

https://www.wsj.com/market-data/quotes/index/DJIA/historical-prices

https://polymarket.com/event/rut-up-or-down-on-november-4-2025

https://www.statmuse.com/money/ask/dow-jones-average-over-last-5-years

https://fortune.com/article/current-price-of-gold-11-04-2025/

https://www.kitco.com/news/article/2025-11-04/gold-market-analysis-november-4-key-intra-day-price-entry-levels-active

https://www.reuters.com/business/energy/oil-steadies-market-digests-opec-output-plans-2025-11-04/

https://www.dtnpf.com/agriculture/web/ag/news/world-policy/article/2025/11/04/oil-falls-dollar-rall-stockpile

https://tradingeconomics.com/commodity/gold

https://www.angelone.in/news/commodities/gold-and-silver-prices-today-november-4-2025-check-latest-city-wise-rates-across-india

https://www.indexbox.io/blog/oil-prices-settle-lower-as-dollar-strengthens-and-manufacturing-weakens/

https://www.usagold.com/daily-gold-price-history/

https://www.jmbullion.com/charts/silver-prices/?WickedSource=Microsoft&WickedId=80745573228499%7Cgold+price+per+gram%7Ce&wcid=140827704

https://www.bloomberg.com/news/articles/2025-11-03/latest-oil-market-news-and-analysis-for-nov-4

https://www.forbes.com/advisor/investing/gold-price/

https://www.gmanetwork.com/news/money/companies/964673/oil-price-hike-november-4-2025/story/

by Vista Partners LLC November 4, 2025

Hertz Shifts Gears: Record Profits and Utilization Drive Rental Giant’s Comeback -( $HTZ )

Hertz (HTZ), a name most often associated with dodging airport shuttle buses and wrestling with trunk latches, has now shifted gears—and not just into reverse. The company just reported its best third-quarter results since 2018, apparently trading old rental car jokes for serious operational discipline and a touch of digital swagger. Revenue surged to $2.5 billion, driven by a “Back-to-Basics” strategy that, unlike most gym memberships, actually delivered results: $184 million in net income, positive EPS for the first time in two years, and enough adjusted EBITDA muscle ($190 million) to make Wall Street sit up straight.

Record Utilization, Fewer Parking Lot Tales

Hertz’s fleet utilization raced past 84%, a figure not seen since the pre-pandemic days of rampant suitcase inflation and questionable GPS routing. This wasn’t just statistical deja vu. By keeping its vehicles out of service shorter, Hertz achieved North America’s highest customer satisfaction scores in recent memory—a nearly 50% year-over-year leap, according to Net Promoter Scores. That’s no small feat for a company whose customer service reputation historically fell somewhere between airline meal reviews and lost-luggage hotline hell.

Fleet Refresh, Digital Dashboards—The New Road Trip

Under CEO Gil West, Hertz replaced its aging fleet with newer models, hitting depreciation per unit below $300—meaning cars are worth more, use less oil, and possibly smell less like mystery cologne. The digital transformation also rolled out, with a revamped Hertz app and plans for 65% of transactions to be digital by late 2025. If it sounds like Hertz is becoming part software company, you’re not wrong; the app just might be more reliable than the average GPS unit that says “arrived” two blocks from the terminal.

More Green, Less Drama

But it’s not all digital crusades and fleet swaps. Hertz has bumped up its eco-friendly vehicle offerings by 30% and signed partnerships to expand in untapped markets, positioning itself for the coming EV and mobility shakeups. The rental giant’s fleet is now mostly less than a year old, a milestone that would make any used-car manager weep with envy.

Humor in the Numbers

For investors, Hertz’s transformation story is a rare mix: strong revenue growth, a plan for $1 billion EBITDA by 2027, and enough liquidity ($2.2 billion) to buy a few airport sandwiches… or maybe one overpriced lounge pass. The only buzzkill? A mountain of $18.9 billion in debt remains, though bondholders are reportedly celebrating extension parties through 2028.

The Road Ahead

Hertz is shooting for the moon—or at least the 3-6% EBITDA margin stratosphere by 2026. If their operational discipline keeps up and supply chains don’t go on vacation, the company’s biggest hurdles may soon be convincing people the app won’t misplace your reservation and ensuring the rental lot snack machines actually work.

For now, Hertz’s road to redemption is paved with new cars, gleaming balance sheets, and a quiet promise that today’s rental experience might finally be less adventure and more arrival.

Sources

by Vista Partners LLC November 4, 2025

Microsoft’s $9.7 Billion AI Cloud Deal: How Bitcoin Miners Became Data Center Superstars -( $MSFT $IREN $BTC $DELL $NVDA )

Microsoft’s (MSFT) blockbuster $9.7 billion, five-year deal with Aussie firm IREN offers a masterclass in how to turn crypto winters into a sunny forecast for AI—and yes, it’s billions, not millions, even though Wall Street still double-checks its calculators at the shock. Under the agreement, IREN will supply Microsoft with premium cloud infrastructure powered by Nvidia’s latest chips, helping the Redmond giant keep pace with ravenous AI demand—because apparently, ChatGPT doesn’t run on hopes and dreams.

Bitcoin Miners: From Crypto Cowboys to AI Sheriffs

Not too long ago, Bitcoin (BTC) miners like IREN Limited (IREN) were bootstrapping their future on digital gold, only to discover that margins melt faster than ice cream in a Texas summer. With Bitcoin’s infamous “halving” events slashing mining rewards and wild price swings squeezing profits, smart miners pivoted to high-performance computing—a.k.a. renting out their data center horsepower to the world’s hungriest AI workloads. The result? AI is now their new best friend, and unlike Bitcoin, it doesn’t require a speculative fortune teller.

The IREN-Microsoft Deal: Power, Chips, and Liquid Ambitions

Microsoft’s contract with IREN isn’t just large, it’s transformative. IREN, riding a six-fold surge in share price this year (not bad for a miner reborn as an AI landlord), will deploy Nvidia’s ultra-hot GB300 processors at its megalithic Childress, Texas campus, serving 200 megawatts of AI-ready infrastructure. Microsoft gets priority access to cloud resources without the pain of building new data centers or fighting for grid hookups—with IREN’s entirely renewables-powered setup ticking all the ESG boxes that tech investors love.

For extra spice, the deal comes with strict performance deadlines. If IREN doesn’t deliver on its ambitious rollout timelines, Microsoft can pull the plug faster than you can say “liquid cooling”. Meanwhile, the $5.8 billion that IREN will spend on chips from Dell (DELL) and Nvidia (NVDA) will be financed, in part, by Microsoft’s prepayment—showing that even global titans appreciate layaway plans.

The Humor in the Numbers

So what do you get when a Bitcoin miner walks into an AI bar with a fortune in Nvidia chips? A stock chart that’s gone vertical—IREN soared over 500% this year, giving Wall Street analysts legitimate neck strain. Some industry insiders have joked that if this keeps up, “Bitcoin mining” will become shorthand for “tech company ready to pivot at a moment’s notice.”

Wall Street’s Take: AI Is the New Digital Gold

The message from Wall Street is clear: AI infrastructure is the new gold mine, and companies repurposing their crypto operations for AI are winning investor attention—and contracts with the likes of Microsoft and Amazon. Industry consensus suggests that leveraging pre-existing power assets and data centers can shave years off data infrastructure build times, making miners essential participants in the AI arms race.

Final Thought

Microsoft’s megadeal signals that the age of pure Bitcoin mining is winding down in favor of high-performance computing rentals, where crypto veterans lend their grid muscle to the likes of OpenAI, Microsoft, and more. So next time someone asks if it pays to pivot—just point to IREN’s share price, and tell them it’s “AI or bust.”

Sources

by Vista Partners LLC November 1, 2025

Macroeconomic Reports and Federal Reserve

Tariffs and Government Shutdown Drama

Noteworthy Company News and Performance

Commodities and Crypto

VP Watchlist Updates

Sources

Strong Clinical Momentum

Solid Financial Performance

Outlook – The Right Dose, the Right Place, the Right Amount of Time

Sources

Nostalgia, Chicken, and Surging Sales

Value Meals and Deal Drama

The Market’s Taste for Chicken

Financials, with a Side of Humor

Closing Observations

Sources

AI Risks: Smarter Than Your Average Mogul?

Corporate Responsibility: A Mixed Bag

Global Collider: U.S., China, and Funding Woes

Musk Will Get Richer, You Might Get Unemployed

Is This Time Different? Hold the Optimism

Looking for a “Chernobyl Moment”

The Wrap-Up: The Godfather’s Regrets?

A Billion-Dollar Takeoff

Unconventional Pathways, Quirky Culture

IPO Under Unusual Circumstances

Market Impact and Flying Into the Future

Sources

Top Performers

VP Watchlist Updates

Sources

Record Utilization, Fewer Parking Lot Tales

Fleet Refresh, Digital Dashboards—The New Road Trip

More Green, Less Drama

Humor in the Numbers

The Road Ahead

Sources

Bitcoin Miners: From Crypto Cowboys to AI Sheriffs

The IREN-Microsoft Deal: Power, Chips, and Liquid Ambitions

The Humor in the Numbers

Wall Street’s Take: AI Is the New Digital Gold

Final Thought

Sources

Your Guide To Staying Informed In The Markets